Regarding the potential role of MTH1 as a biomarker in gastric cancer, although overexpression of mRNANUDT1 and protein has been observed and is in agreement with publicly available database information, more clinical confirmation is needed. The gene discussed is NUDT1; the disease is gastric cancer.